Epidemiology of Non-SARS-CoV2 Human Coronaviruses (HCoVs) in People Presenting with Influenza-like Illness (ILI) or Severe Acute Respiratory Infections (SARI) in Senegal from 2012 to 2020Article Published on 2022-12-212023-07-11 Journal: Viruses [Category] COVID19(2023년), [키워드] coronavirus characterization Epidemiology HCoV-229E HCoV-HKU1 HCoV-NL63 HCoV-OC43 human coronaviruses ILI respiratory infections. SARI [DOI] 10.3390/v15010020 PMC 바로가기
Calibration of Methods for SARS-CoV-2 Environmental Surveillance: A Case Study from Northwest TuscanyArticle Published on 2022-12-092023-07-11 Journal: International Journal of Environmental Research an [Category] COVID19(2023년), [키워드] HCoV-229E mengovirus VMC0 SARS-CoV-2 wastewater surveillance Wastewater-based epidemiology. [DOI] 10.3390/ijerph192416588 PMC 바로가기
Antigenic mapping reveals sites of vulnerability on α-HCoV spike proteinArticle Published on 2022-11-042022-11-15 Journal: Communications Biology [Category] SARS, 진단, [키워드] antigenic appear characterized conserved distal domain dominant effective epitope Epitopes feasibility HCoV-229E HCoV-NL63 highlight human coronavirus imperative N-terminal domain Neutralizing neutralizing antibody panel of antibody Protein RBD Receptor binding domain receptor binding site recognize representing reveal S protein S proteins similarity spike Spike protein subset the SARS-CoV-2 understanding Vaccine design Vaccine development [DOI] 10.1038/s42003-022-04160-8 PMC 바로가기
More tools for our toolkit: The application of HEL-299 cells and dsRNA-nanoparticles to study human coronaviruses in vitroArticle Published on 2022-11-012022-11-15 Journal: Virus research [Category] SARS, 치료법, 치료제, [키워드] ACE2 receptor Analysis Antiviral antiviral genes antiviral response antiviral therapy can be used Cell cell line cells Combination competent Complete coronavirus Coronavirus replication CXCL10 cytidylic acid double-stranded expand fibroblast Gene Expression HCoV-229E HCoV-NL63 help Human human coronavirus human coronaviruses human lung IFN IFNs IFNβ in vitro increase in inducer Infection inhibit innate immune interferons ISG15 limit MERS-CoV Nanoparticles Pathogens Poly I:C. post infection PROTECT provided required SARS-CoV-2 SARS-CoV-2 pandemic stimulate translated Treatment Type I IFN type I interferon virus production were infected while [DOI] 10.1016/j.virusres.2022.198925 PMC 바로가기
Pulsed-Xenon Ultraviolet Light Highly Inactivates Human Coronaviruses on Solid Surfaces, Particularly SARS-CoV-2Article Published on 2022-10-232023-07-10 Journal: International Journal of Environmental Research an [Category] COVID19(2023년), [키워드] coronavirus HCoV-229E MERS-CoV pulsed-xenon ultraviolet SARS-CoV-2 Virus inactivation. [DOI] 10.3390/ijerph192113780 PMC 바로가기
Seasonality of Common Human Coronaviruses, United States, 2014-20211Article Published on 2022-10-012022-11-15 Journal: Emerging Infectious Diseases [Category] 치료기술, [키워드] 2019 novel coronavirus disease acute respiratory syndrome Alpha alphacoronavirus annual variation applied Betacoronavirus Better can be used common coronavirus coronavirus disease Coronaviruses COVID-19 defined enteric expected HCoV-229E HCoV-HKU1 HCoV-NL63 Human human coronavirus Mild Novel coronavirus occurred offset parameter predominant respiratory respiratory infections retrospective SARS-CoV-2 seasonal seasonality seasons severe acute respiratory syndrome coronavirus 2 System the United State United States upper respiratory viruses with COVID-19 zoonoses zoonoses. [DOI] 10.3201/eid2810.220396 PMC 바로가기
Semisynthetic teicoplanin derivatives with dual antimicrobial activity against SARS-CoV-2 and multiresistant bacteriaArticle Published on 2022-09-262022-11-15 Journal: Scientific Reports [Category] SARS, 치료제, [키워드] active against Affect Antibiotics antimicrobial Antiviral approved Bacteria Bacterial cells Co-infection Compound conjugate coronavirus derivative drug drugs effective Efficacy Endemic endosomal entry enzyme HCoV-229E human Calu-3 cell hydrophobic infected with SARS-CoV-2 inhibiting inhibition assay inhibitor membrane modifications Prevent Prognosis risk RNA virus SARS-CoV-2 SARS-CoV-2 replication Seven shown VeroE6 cells [DOI] 10.1038/s41598-022-20182-y PMC 바로가기
Are higher antibody levels against seasonal human coronaviruses associated with a more robust humoral immune response after SARS-CoV-2 vaccination?Article Published on 2022-09-082022-11-15 Journal: Frontiers in Immunology [Category] SARS, 진단, [키워드] adjusted affected age anti-spike antibodies anti-spike antibody anti-Spike IgG anti-spike IgG antibodies Anti-spike IgG antibody antibodies antibody Antibody concentrations antigens appear association baseline Blood Canada coronavirus coronavirus Correlation analysis COVID-19 COVID-19 infection COVID-19 testing demonstrated determine Endemic HCoV-229E HCoV-HKU1 HCoV-NL63 HCoV-OC43 human coronavirus human endemic coronaviruses humoral immune response IgG levels Immunity include increases in linear relationship Multiple regression multiple regression model not affect Observational cohort study participant Participants performed positive provided questionnaire data robust Sample SARS-CoV-2 SARS-CoV-2 antibodies SARS-CoV-2 vaccines Scatter plot significant difference significantly higher tested vaccinated individual vaccination vaccination. [DOI] 10.3389/fimmu.2022.954093 PMC 바로가기
Pre-existing anti-HCoV-OC43 immunity influences the durability and cross-reactivity of humoral response to SARS-CoV-2 vaccinationArticle Published on 2022-09-022022-11-15 Journal: Frontiers in Cellular and Infection Microbiology [Category] SARS, 진단, 치료기술, [키워드] Analysis anti-HCoV-OC43 anti-nucleoprotein anti-RBD antibodies antibody binding chemiluminescence immunoassay conducted coronavirus coronavirus vaccine correlation cross-protection cross-reactivity demonstrated detect ELISA enzyme-linked immunosorbent HCoV-229E HCoV-HKU1 HCoV-NL63 HCoV-OC43 humoral Humoral response IgG Immunity Immunoglobulin inactivated individuals influence neutralization Neutralization antibody neutralizing antibody Outbreaks performed positively correlated Protective protective immunity Protein pseudovirus S1 IgG S1 subunit SARS-CoV-2 SARS-CoV-2 vaccination SARS-CoV-2 vaccine seasonal coronavirus seasonal human coronavirus. second vaccination statistically significant vaccination Vaccine vaccinee vaccinees viral neutralization [DOI] 10.3389/fcimb.2022.978440 PMC 바로가기
Severe Acute Respiratory Syndrome Coronavirus 2 Vaccination Boosts Neutralizing Activity Against Seasonal Human Coronaviruses중증 급성 호흡기 증후군 코로나바이러스 2 백신 접종은 계절성 인간 코로나바이러스에 대한 중화 활성을 향상시킵니다Article Published on 2022-08-242022-09-11 Journal: Clinical Infectious Diseases: An Official Publicat [Category] SARS, 치료법, [키워드] 229E activity acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus 2 Against analyzed average BNT162b2 causative agent ChAdOx1 ChAdOx1 nCoV-19 circulating colds common cold Concentration coronavirus coronavirus 2 coronavirus disease Coronavirus disease 2019 COVID-19 COVID-19 vaccination COVID-19 vaccinations cross-neutralization cross-protection determined by Efficiency Endemic Gene Expression HCoV HCoV-229E HCoV-NL63 HCoV-OC43 HCoVs Heterologous Huh-7 cells Human human coronavirus incubated individual inhibitory activity MERS MERS-CoV Middle East Middle East respiratory syndrome MOST neutralization neutralize Neutralizing activity NL63 nucleocapsid expression OC43 Preexisting immunity pseudoparticle pseudovirion pseudovirions reporter reporter gene respiratory SARS-CoV-1 SARS-CoV-2 SARS-CoV-2 vaccination seasonal seasonal coronavirus seasonal coronaviruses seasonal coronaviruses. sera severe acute respiratory syndrome Coronavirus significantly increased Spike proteins these viruses vaccination Viral RNA virus [DOI] 10.1093/cid/ciac057 PMC 바로가기 [Article Type] Article